» Articles » PMID: 27599290

Hypoxia-inducible Factors: Key Regulators of Myeloid Cells During Inflammation

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2016 Sep 7
PMID 27599290
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

Hypoxia is a prominent characteristic of many acute or chronic inflammatory diseases, and exerts significant influence on their progression. Macrophages and neutrophils are major cellular components of innate immunity and contribute not only to O2 deprivation at the site of inflammation, but also alter many of their functions in response to hypoxia to either facilitate or suppress inflammation. Hypoxia stabilizes HIF-αs in macrophages and neutrophils, and these O2-sensitive transcription factors are key regulators of inflammatory responses in myeloid cells. In this review, we will summarize our current understanding of the role of HIF-αs in shaping macrophage and neutrophil functions in the pathogenesis and progression of multiple inflammatory diseases.

Citing Articles

Exploring the Ascorbate Requirement of the 2-Oxoglutarate-Dependent Dioxygenases.

Smith-Diaz C, Das A, Jurkowski T, Hore T, Vissers M J Med Chem. 2025; 68(3):2219-2237.

PMID: 39883951 PMC: 11831678. DOI: 10.1021/acs.jmedchem.4c02342.


A Hypoxia-Inflammation Cycle and Multiple Sclerosis: Mechanisms and Therapeutic Implications.

Soroush A, Dunn J Curr Treat Options Neurol. 2024; 27(1):6.

PMID: 39569339 PMC: 11573864. DOI: 10.1007/s11940-024-00816-4.


Vax-Innate: improving therapeutic cancer vaccines by modulating T cells and the tumour microenvironment.

Baharom F, Hermans D, Delamarre L, Seder R Nat Rev Immunol. 2024; 25(3):195-211.

PMID: 39433884 DOI: 10.1038/s41577-024-01091-9.


Hypoxia-inducible factor-1α promotes macrophage functional activities in protecting hypoxia-tolerant large yellow croaker () against infection.

Zhang Y, Wang X, Gao Z, Li X, Meng R, Wu X Front Immunol. 2024; 15:1410082.

PMID: 39156889 PMC: 11327042. DOI: 10.3389/fimmu.2024.1410082.


Maximizing Treatment Options for IBD through Drug Repurposing.

Barjasteh A, Al-Asady A, Latifi H, Al Okla S, Al-Nazwani N, Avan A Curr Pharm Des. 2024; 30(32):2538-2549.

PMID: 39039672 DOI: 10.2174/0113816128318032240702045822.


References
1.
Zhou J, Schmid T, Brune B . Tumor necrosis factor-alpha causes accumulation of a ubiquitinated form of hypoxia inducible factor-1alpha through a nuclear factor-kappaB-dependent pathway. Mol Biol Cell. 2003; 14(6):2216-25. PMC: 194872. DOI: 10.1091/mbc.e02-09-0598. View

2.
Arsham A, Howell J, Simon M . A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets. J Biol Chem. 2003; 278(32):29655-60. DOI: 10.1074/jbc.M212770200. View

3.
Choe S, Shin K, Ka S, Lee Y, Chun J, Kim J . Macrophage HIF-2α ameliorates adipose tissue inflammation and insulin resistance in obesity. Diabetes. 2014; 63(10):3359-71. DOI: 10.2337/db13-1965. View

4.
Maruotti N, Cantatore F, Crivellato E, Vacca A, Ribatti D . Macrophages in rheumatoid arthritis. Histol Histopathol. 2007; 22(5):581-6. DOI: 10.14670/HH-22.581. View

5.
Rahtu-Korpela L, Maatta J, Dimova E, Horkko S, Gylling H, Walkinshaw G . Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis. Arterioscler Thromb Vasc Biol. 2016; 36(4):608-17. DOI: 10.1161/ATVBAHA.115.307136. View